Similar articles

• Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.

  DaSilva I, Huerta A, Quintana L, Redondo B, Iglesias E, Draibe J, Praga M, Ballarín J, Díaz-Encarnación M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). DaSilva I, et al. BioDrugs. 2017 Jun;31(3):239-249. doi: 10.1007/s40259-017-0221-x. BioDrugs. 2017. PMID: 28534103
• Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.

  Sinha A, Bagga A, Gulati A, Hari P. Sinha A, et al. Pediatr Nephrol. 2012 Feb;27(2):235-41. doi: 10.1007/s00467-011-1997-4. Epub 2011 Sep 16. Pediatr Nephrol. 2012. PMID: 21922213
• Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.

  Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L. Wu B, et al. Nephrology (Carlton). 2015 Jan;20(1):18-24. doi: 10.1111/nep.12351. Nephrology (Carlton). 2015. PMID: 25312783 Clinical Trial.
• Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

  Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K. Kamei K, et al. Pediatr Nephrol. 2020 Jan;35(1):17-24. doi: 10.1007/s00467-018-4166-1. Epub 2018 Dec 18. Pediatr Nephrol. 2020. PMID: 30564879 Review.
• Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults.

  Iwabuchi Y, Moriyama T, Itabashi M, Takei T, Nitta K. Iwabuchi Y, et al. Contrib Nephrol. 2018;195:12-19. doi: 10.1159/000486930. Epub 2018 May 7. Contrib Nephrol. 2018. PMID: 29734146 Review.